Replies to post #353462 on Bioelectronics Corp (BIEL)

[GetSeriousOK]

That's not how arbitration works. Mundipharma won't have to hand over $13 million to BIEL.

Mundipharma has expensive lawyers to go over their contracts. We can't read the actual contract, but there's no way Mundipharma signed a binding promise to buy $14M of product no matter what happens.

BIEL's contract was a Distribution Agreement. Before you start pumping $13 million awards, maybe look up what "arbitration" and "distribution agreement" mean.

From the annual statement, "The Company has entered into third-party funding arrangements." That's a specific service offered by SIAC. That's how BIEL found Oon & Bazul.

BIEL might benefit somehow from this arbitration case, and they might get nothing, but stop pumping $13M awards.

[toohot]

Agreed. Mundi owes BIG time!




BUY $BIEL$

[art2426]

>>>"Assuming we secure the litigation financing, we intend to pursue our action against Mundipharma."<<<


LOL, admitting they do not have enough money for retaining an attorney. Not surprising after seeing those financials. So NOW they are seeking financing to 'pursue action against Mundipharma'. --- LOL< well just add those liabilities to the already $18,083,918 amount that is shown in their latest financials that they OWE.

[art2426]

>>> Looking at BIEL's total revenue in 2018 & 2019 ($2 million), the time frame before the Purdue BK when MundiPharma was actively promoting ActiPatch, it is doubtful that Mundi purchased more than $1 million in devices from BIEL. This could indicate a liability of $13 million. BIEL would probably have a 50/50 split with the law firm or an entity that is financing the arbitration costs.<<<


Is that your assumption?